Erratum: Richard Havel, Howard Eder, and the evolution of lipoprotein analysis (Journal of Clinical Investigation (2004) 114 (1034-1037) (doi: 10.1172/JCI200423198));Richard Havel, Howard Eder, and the evolution of lipoprotein analysis

Journal of Clinical Investigation

Volumn 114, Issue 8, 2004, Pages 1034-1037

  Grundy, Scott M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; LIPID; LIPOPROTEIN;

ATHEROSCLEROSIS; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVIEW; ULTRACENTRIFUGATION;

EID: 9644255794     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200423198E1     Document Type: Erratum

References (36)

1. Havel, R.J., Eder, H.A., and Bragdon, J.H. 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34:1345-1353.
2. Macheboeuf, M. 1930. Recherches sur les phosphoaminolipides et les sterides du serum et du plasma sanguins: I. Entrainement des phospholipids, des sterols et des sterides par les diverses fractions au cours du fractionnement des proteides du serum. Bull. Soc. Chim. Biol. 223:1-99.
3. Bennhold, H. 1932. Ueber die vehikelfunction der serumeiweiskorper. Ergebn. Inn. Med. Kinderheilkd. 42:273-375.
4. Cohn, E.J., et al. 1946. Preparation and properties of serum and plasma proteins: IV. System for separation into fractions of protein and lipoprotein components of biological tissues and fluids. J. Am. Chem. Soc. 68:459-475.
5. Blix, G., Tiselius, A., and Svensson, H. 1941. Lipids and polysaccharides in electrophoretically separated blood serum proteins. J. Biol. Chem. 137:485-494.
6. Pedersen, K.O. 1945. On a low-density lipoprotein appearing in normal human plasma. J. Phys. Colloid Chem. 51:156-163.
7. Gofman, J., Lindgren, F., and Elliott, H. 1949. Ultracentrifugal studies of lipoproteins of human serum. J. Biol. Chem. 179:973-978.
8. Gofman, J., et al. 1950. The role of lipids and lipoproteins in atherosclerosis. Science. 111:166-171.
9. Lindgren, F.T., Elliott, H.A., and Gofman, J.W. 1951. Thte ultracentrifugal characterization and isolation of human blood lipids and lipoproteins, with application to the study of atherosclerosis. J. Phys. Colloid Chem. 55:80-93.
10. De Lalla, O.F., and Gofman, J.W. 1954. Ultracentrifugal analysis of serum lipoproteins. In Methods of biochemical analysis. Volume 1. D. Glick, editor. Wiley. New York, New York, USA. 459-478.
11. Gofman, J.W., Glazier, F., Tamplin, A., Strishower, B., and De Lalla, O. 1954. Lipoproteins, coronary heart disease and atherosclerosis. Physiol. Rev. 34:589-607.
12. Krauss, R.M., and Burke, D.J. 1982. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J. Lipid Res. 23:97-104.
13. Krauss, R.M. 1995. Dense low density lipoproteins and coronary artery disease. Am. J. Cardiol 75:53B-57B.
14. Havel, R.J. 1956. Evidence for the participation of lipoprotein lipase in the transport of chylomicrons. In Third International Conference on Biochemical Problems of Lipids: the Blood Lipids and the Clearing Factor. July 26-28, 1956. Brussels, Belgium. 265-273.
15. Baxter, J.H., Goodman, H.C., and Havel, R.J. 1960. Serum lipid and lipoprotein alterations in nephrosis. J. Clin. Invest. 39:455-465.
16. Lindgren, F.T., Nichols, A.V., and Freeman, N.K. 1955. Physical and chemical composition studies on the lipoproteins of fasting and heparinized human sera. J. Phys. Chem. 59:930-938.
17. The Technical Group and Committee on Lipoproteins and Atherosclerosis. 1956. Evaluation of serum lipoprotein and cholesterol measurements as predictors of clinical complications of atherosclerosis. Circulation. 14:691-741.
18. Lees, R.S., and Hatch, F.T. 1963. Sharper separation of lipoprotein species by paper electrophoresis in albumin-containing buffer. J. Lab. Clin. Med. 61:518-528.
19. Fredrickson, D.S., Levy, R.I., and Lees, R.S. 1967. Fat transport in lipoproteins: An integrated approach to mechanisms and disorders [review]. N. Engl. J. Med. 276:148-156.
20. Fredrickson, D.S. 1993. Phenotyping. On reaching base camp (1950-1975). Circulation. 87(Suppl. 4): III1-III15.
21. Burstein, M., and Samaille, J. 1958. Determination of serum beta-lipoproteins after selective precipitation by heparin. Presse Med. 66:974-975.
22. Friedewald, T., Levy, R.I., and Frederickson, D.S. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 6:499-503.
23. [Anonymous]. 1984. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary hearr disease. JAMA. 251:351-364.
24. [Anonymous]. 1984. The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA. 251:365-374.
25. Hulley, S.B., Rosenman, R.H., Bawol, R.D., and Brand, R.J. 1980. Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease. N. Engl. J. Med. 302:1383-1389.
26. Austin, M.A., Hokanson, J.E., and Edwards, K.L. 1998. Hypertriglyceridemia as a cardiovascular risk factor. Am. J. Cordiol. 81:7B-12B.
27. Assmann, G., Schulte, H., Funke, H., and von Eckardstein, A. 1998. The emergence of triglycerides as a significant independent risk factor in coronary artery disease. Eur. Heart J. 19(Suppl. M):M8-M14.
28. Frost, P.H., and Havel, R.J. 1998. Rationale for use of non-high-density lipoprotein cholesterol rather than low-density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and thetapy. Am. J. Cardiol. 81:26B-31B.
29. Garg, A., and Grundy, S.M. 1990. Management of dyslipidemia in NIDDM [review]. Diabetes Care. 13:153-169.
30. National Cholesterol Education Program. 2002. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Choiesterol in Adults (Adult Treatment Panel III): final report. Circulation. 106:3143-3421.
31. Sniderman, A.D. 2002. How, when, and why to use apolipoprotein B in clinical practice. Am. J. Cardiol 90:48i-54i.
32. Alaupovic, P. 1991. Apolipoprotein composition as the basis for classifying plasma lipoproteins. Characterization of apoA- and apoB-containing lipoprotein families. Prog. Lipid Res. 30:105-138.
33. Alaupovic, P. 1996. Significance of apolipoproteins for structure, function, and classification of plasma lipoproteins. Meth. Enzymol. 263:32-60.
34. De Lalla, O.F., Elliott, H.A., and Gofman, J.W. 1954. Ultracentrifugal studies of high-density serum lipoproteins in clinically healthy adults. Am. J. Physiol. 179:333-337.
35. Gidez, L.I., Miller, G.J., Burstein, M., Slagle, S., and Eder, H.A. 1982. Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J. Lipid Res. 23:1206-1223.
36. Asztalos, B.F., Sloop, C.H., Wong, L., and Roheim, P.S. 1993. Two-dimensional electrophoresis of plasma lipoproteins: recognition of new apo A-I-containing subpopulations. Biochim. Biophys. Acta. 1169:291-300.